Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant to Promote Colonization Resistance to Staphylococcus Aureus

NCT05695196 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT05695196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05695196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant to Promote Colonization Resistance to Staphylococcus Aureus
Lead sponsor
Johns Hopkins University
Phase
Phase 1
Overall status
Active, not recruiting
Start date
October 25, 2023
Completion date
December 1, 2026
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microbial colonization, neonatal infection, staphylococcus aureus